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Abstract 
Machine Learning is proving invaluable across disciplines. However, its success is often limited 
by the quality and quantity of available data, while its adoption by the level of trust afforded by 
given models. Human vs. machine performance is commonly compared empirically to decide 
whether a certain task should be performed by a computer or an expert. In reality, the optimal 
learning strategy may involve combining the complementary strengths of man and machine. 
Here we present Expert-Augmented Machine Learning (EAML), an automated method that 
guides the extraction of expert knowledge and its integration into machine-learned models. We 
use a large dataset of intensive care patient data to predict mortality and show that we can 
extract clinicians’ knowledge using an online platform, help reveal hidden confounders, 
improve generalizability on a different population and learn using less data. EAML presents a 
novel framework for high performance and dependable machine learning in critical 
applications. 

Machine learning (ML) algorithms are proving increasingly successful in a wide range of 
applications but are often data inefficient and may fail to generalize to new datasets. In 
contrast, humans are able to learn with significantly less data by using prior knowledge. 
Creating a general methodology to extract and capitalize on human prior knowledge is 
fundamental for the future of ML. Expert systems, introduced in the 1960s and popularized in 
the 1980s and early 1990s, were an attempt to emulate human decision-making in order to 
address Artificial Intelligence problems1. They involved hard-coding multiple if-then rules 
laboriously designed by domain experts. This approach proved problematic because a very 
large number of rules is usually required, and no procedure exists to generate them 
automatically. In practice, such methods commonly resulted in an incomplete set of rules and 
poor performance. The approach fell out of favor and attention has since been focused mainly 
on ML algorithms requiring little to no human intervention.

Learning algorithms map a set of features to an outcome of interest by taking advantage of the 
correlation structure of the data. The success of this mapping will depend on several factors, 
other than the amount of actual information present in the covariates, including the amount of 
noise in the data, the presence of hidden confounders and the number of available training 
examples. Lacking any general knowledge of the world, it is no surprise that current ML 
algorithms will often make mistakes that would appear trivial to a human.  For example, an 
algorithm trained to estimate the probability of death from pneumonia labeled asthmatic 
patients as having a lower risk of death than non-asthmatics. While misleading, the prediction 
was based on a real correlation in the data: these patients were reliably treated faster and 
received more aggressive treatment, as they should, resulting in consistently better outcomes2. 
Out of context, misapplication of such models could lead to catastrophic results. In a random 
dataset collected to illustrate the widespread existence of confounders in medicine, it was 
found that colon cancer screening and abnormal breast findings were highly correlated to the 
risk of having a stroke, with no apparent clinical justification3. Unfortunately, superior 
performance on a task as measured on test sets derived from the same empirical distribution, 
is often considered to mean that real knowledge has been acquired. In a recent study, 
CheXNet: Radiologist-Level Pneumonia Detection on Chest X-Rays with Deep Learning, 
investigators observed that a Convolutional Neural Network (CNN) outperforms radiologists in 
overall accuracy4. A subsequent study revealed that the CNN was basing its prediction to a 
large extent on pixel information identifying hospitals with higher prevalence of pneumonia and 
labels discriminating regular from portable radiographs, while pathology present in the image 
was sometimes disregarded5,6. It was also shown that performance declined when a model 
trained with data from one hospital was used to predict data from another5. 

Among the biggest challenges for ML in high-stakes domains such as medicine, is therefore to 
automatically extract and incorporate prior knowledge that allows ML algorithms to generalize 
to new cases and learn with less data. In this study, we hypothesized that human experts have 
extensive prior knowledge of causal and correlational physiological relationships that, if 
captured, would help algorithms generalize better. We introduce MediForests, a novel tool to 
automatically acquire priors for a given problem, and Expert-Augmented Machine Learning 
(EAML), an approach that incorporates human expert-derived priors in a ML model. The 
procedure allows training models with 1) less data that are 2) more robust to changes in the 
underlying variable distributions and 3) resistant to performance decay with time. Rather than 
relying on hard-coded and incomplete rulesets, like the early expert systems did, or focusing 
on potentially spurious correlations like current ML algorithms do, EAML guides the acquisition 
of prior knowledge to improve the ML algorithm. We demonstrate the value of MediForests and 
EAML using the MIMIC dataset from the PhysioNet project to predict mortality among intensive 
care unit (ICU) patients7,8. 
MediForests generates problem-specific priors from domain experts 
To automate the generation of problem-specific priors, we developed a multi-step approach. 
First, we trained RuleFit on the MIMIC-II ICU dataset predicting hospital mortality using 
demographic and physiologic input variables that are commonly included in many clinical 
scoring systems9-11. This yielded 126 rules with nonzero coefficients. Using a 70% / 30% 
training / test split, RuleFit achieved a test-set balanced accuracy of 74.4 compared to 67.3 for 
Figure 1. Example of a rule presented to clinicians. Age, Glasgow Coma Scale (1: <6, 2: 6-8, 
3: 9-10, 4: 11-13, 5: 14-15), Ratio of Oxygen Blood concentration to Fractional Inspired 
Oxygen concentration (PaO2/FiO2) and Blood Urea Nitrogen concentration are the variables 
selected for this rule. Clinicians were asked to assess the effect of each rule on mortality risk 
using a 5-point system: highly decrease, moderately decrease, no effect, moderately 
increase, highly increase.
a Random Forest. Previously, Random Forest had been found to be the top performer among a 
library of algorithms on the MIMIC-II dataset12. Subsequently, a committee of 15 clinicians at 
the University of California San Francisco (a different institution from where the data was 
acquired) were asked to categorize the risk of the subpopulations within each rule compared to 
the general population without being shown the empirical risk (Figure 1). On average, clinicians 
took 41 ± 19 minutes to answer 126 questions. 

To prove that we were acquiring valid clinical information, the average of the clinicians’ answers 
for each rule was calculated. Rules were ranked by increasing perceived risk, Rankp. We then 
binned the rules into five groups according to their ranking and plotted the empirical risk by 
group (Figure 2A). There is a monotonic relationship between the average clinicians’ ranking of 
a rule and its empirical risk (mortality ratio). 

Delta ranking helps discover hidden confounders 
The empirical risk ranking of the rules, Ranke, was calculated using the mortality ratio of 
patients within each rule. The delta ranking was defined as ΔR = Ranke - Rankp and is a 
measure of clinicians’ disagreement with the empirical data.  The distribution of ΔR is shown in 
Figure 2 A. Mortality Ratio by average clinicians’ risk ranking. Rules were binned into 
quintiles based on average clinicians’ assessment. The mean empirical risk for each quintile 
was plotted. Error bars indicate 1.96 * standard error B. Distribution of the measure of 
clinicians’ disagreement with the empirical data, ΔR.
Figure 2B. We hypothesized that those rules where ΔR was outside the 90% confidence 
interval were likely to indicate either that clinicians misjudged the risk of the given 
subpopulations or that hidden confounders were modifying the risk. This hypothesis is based 
on the fact that the rules were created by the ML model based on empirical risk, while 
clinicians were estimating risk of each subpopulation based on medical knowledge and 
experience.  We first analyzed those rules where the empirical ranking was significantly smaller 
than the clinicians’ perceived ranking (Table 1A). 

A. Clinician-estimated risk > Empirical risk ∆Ranking
Age=66.15 (16.50-89.29); PaO2/FiO2=332.60 (199.00-2304.76);  
HR=84.00 (0.00-106.00)); GCS=2.00 (1.00-4.00); Renal function=0 (0,1) -49
PaO2/FiO2=332.60 (224.00-955.00); GCS=5.00 (5.00-5.00);

Age=80.92 (74.61-101.45); Renal function=0 (0) -48
GCS=2.00 (1.00-4.00); BUN=15.00 (2.00-24.00); Age=58.76 (16.83-75.15); 
PaO2/FiO2=332.60 (212.00 1942.86); HR=80.00 (0.00-92.00) -47
HR=80.00 (0.00-94.00); GCS=2.00 (1.00-4.00); BUN=15.00 (2.00-24.00);

Age=62.71 (17.19-83.55)); PaO2/FiO2=332.60 (272.00-1942.86) -47
PaO2/FiO2=332.60 (318.57-2223.81); GCS=5.00 (3.00-5.00));

Age=81.22 (73.77-101.45); Renal function=0 (0) -44
HR=103.00 (93.00-171.00); GCS=1.00 (1.00-2.00); 

BUN=14.00 (2.00-23.00); PaO2/FiO2=345.00 (272.00-1939.29) -43
B. Clinician-estimated risk < Empirical risk ∆Ranking
GCS=5.00 (3.00-5.00); Bilirubin=2.70 (1.50-48.00); 
BUN=35.00 (20.00-248.00) 37
GCS=5.00 (4.00-5.00); BUN=44.00 (27.00-272.00); 
BP=91.00 (0.00-108.00) 37
PaO2/FiO2=496.53 (342.31-1942.86); HR=117.00 (107.00-171.00); 
BUN=13.00 (2.00-21.00) 39
PaO2/FiO2=122.93 (20.00-271.43); Age=53.75 (18.34-78.42); 
Bilirubin=3.60 (1.60-59.70) 39
GCS=5.00 (3.00-5.00); Bilirubin=4.00 (1.90-48.00); 
Renal function=1 (1,2,3,4) 55
Renal function=0 (0,1); PaO2/FiO2=470.00 (336.67-2304.76) 56
Table 1. The top 5% rules in which the clinicians perceived risk is greater (A) and less (B) than 
the empirical risk. Rules have been color-coded to indicate similar concepts. Variables likely 
to have driven the response are highlighted in red. Values are shown as Variable=median 
(range).
For those rules in blue, clinicians estimated that patients with a lower heart rate (HR) and 
Glasgow Coma Scale (GCS) score below 13 are at higher risk than that supported by the data. 
For those rules in green, clinicians appeared to overestimate the mortality risk of old age. 
However, although it is true that older patients are at higher risk as generally expected9,10,13, the 
data suggests that being older than 80 years old does not automatically place patients at 
higher risk. Finally, the last rule in Table 1A indicates the discovery of a hidden confounder.  In 
the MIMIC dataset, the PhysioNet team decided to assign a value of 3 on the original GCS 
scale to intubated patients; this was corroborated in correspondence with the PhysioNet 
administrators. This is the lowest score on the GCS scale, and indicates that a patient is 
unresponsive to external stimuli. In the case of intubated patients, this is usually because of 
sedation, instead of severe neurological damage14.  Because the intubation status had not 
been initially collected, we reconstructed the same group of patients using MIMIC-III data and 
validated the hypothesis8.  Although it is not clear what value of GCS should be assigned to 
them,14 those patients with a lower GCS (<8) and who are not intubated (N = 1236) have a 
mortality risk of 0.28. Conversely, intubated patients (N = 6493) have a significantly lower 
mortality ratio of 0.19.  The fact that intubated patients have a GCS of 3 in the MIMIC-II dataset 
has largely been ignored in the literature and was only briefly mentioned by the PhysioNet team 
in the calculation of the SOFA score in the MIMIC-III dataset15. 

Table 1B shows the top 5% of the rules where the clinicians’ ranking is lower than the empirical 
ranking.  Here we find that clinicians have underestimated the influence of high blood urea 
nitrogen (BUN) or high bilirubin (rules in blue and orange), although it is known that these 
variables affect mortality16-18.  The disagreement with the rules in green allowed us to identify 
another important issue with the data: clinicians assigned a lower risk to patients with high 
ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) than is 
supported by empirical data. In MIMIC-II, 54% of patients had missing values for PaO2/FiO2, 
and they were imputed with the mean value (332.60), which is very close to the value used by 
the rules in Table 1B (342.31 and 336.67 respectively). We discovered that PaO2/FiO2 values 
were not missing at random. 94.2% of patients (N = 14430) with missing values for PaO2/FiO2 
were not intubated, while 60.35% of patients with values for PaO2/FiO2 were intubated.  
Patients that were not intubated and had a PaO2/FiO2 greater than 336.67 had a mortality ratio 
of 0.046, which would agree with the clinicians’ assessment. In contrast, patients that were 
intubated and had a PaO2/FiO2 greater than 336.67 had a mortality ratio of 0.13. Since this is 
approximately 60% of patients, they dominated the mortality risk on these rules (e.g. 0.10 for 
the last rule on Table 1B). As such, clinicians are again estimating risk based on their 
understanding of the effects of PaO2/FiO2 on mortality, while the algorithm has learned the 
effect of a hidden confounder; intubated vs. not intubated. To confirm this, we predicted 
intubation status in MIMICIII patients from the other covariates and achieved 97% mean 
accuracy using 10-fold crossvalidation. This is especially troublesome because PaO2/FiO2 was 
selected by Random Forest as the most important variable in predicting mortality and was also 
selected as the most important variable driving clinicians’ answers (Figure 3). The underlying 
reason in each case is however very different, as the algorithm is using PaO2/FiO2 as a proxy 
of intubation while clinicians are answering based on their understanding of physiology. 

Expert-Augmented Machine Learning improves out-of-sample performance 
The MIMIC dataset provided an ideal scenario to test whether MediForests + EAML can make 
models more robust to variable shifts or decay of accuracy with time. We built models 
combining clinicians’ answers and the MIMIC-II dataset (collected 2001-2008). We then 
evaluated these models on two sets of the MIMIC-III data: MIMIC-III1,  which utilizes the same 
patients as in MIMIC-II but has different values of the input variables due to recoding of the 
underlying tables by the PhysioNet project and MIMIC-III2 (collected 2008-2012), which 
consists of patients treated in the four years that followed the acquisition of MIMIC-II.  Figure 
4A illustrates an example of a variable distribution change from MIMIC-II to MIMIC-III1. 

Figure 4B illustrates the performance of models trained on 70% of MIMIC-II and evaluated on 
MIMIC-II (30% random subsample), MIMIC-III1 and MIMIC-III2. To demonstrate the effect of 
clinicians’ knowledge, we first organized the rules into 5 categories according to a histogram of 
Figure 3. Variable importance estimated using a Random Forest model predicting mortality 
(A), and clinicians’ assessments (B). While PaO2/FiO2 is the most important variable in both 
cases, in the former case it is used to learn intubation status, while in the latter clinicians are 
responding based on its physiological influence on mortality. 
the absolute value of ΔR, with ΔR = 0 reflecting those rules in which clinicians agreed the most 
with the empirical data and 5 the least. The effect of building different models by serially 
removing rules with increasing ΔR is illustrated in Figure 4B. This process can be considered as 
a hard EAML, where those rules that disagree more than a certain threshold are infinitely 
penalized (i.e. discarded) while those below the threshold are penalized by a constant. Since 
these rules were selected by RuleFit using the empirical distribution on MIMIC-II, getting rid of 
rules adversely affects performance (AUC) in the training data and in the testing set which 
originates from the same empirical distribution (Figure 4B). A different scenario emerges when 
these models are tested on both MIMIC-III1 and MIMIC-III2. In this case, penalizing those rules 
Figure 4.  Variable shifts, crossvalidation and out-of-sample testing: Changes in heart rate 
distribution from MIMIC-II to MIMIC-III (A). Models were trained on MIMIC-II data using 
different subsets of rules defined by the extent of clinicians’ agreement with the empirical risk 
(delta ranking, ΔR) (B). Mean AUC of models trained on MIMIC-II and tested on MIMIC-III (C) 
and models trained and tested on MIMIC-III (D). Subsamples of different sizes were used for 
each subset of rules defined by ΔR to test the hypothesis that eliminating bad rules helps the 
algorithm train with less data. Error bars represent 1 standard deviation across 10 stratified 
subsamples.
where clinicians disagree the most with the empirical data improves performance. When only 
rules with ΔR = 0 are left (N = 53 of 126 rules), however, performance decreases, Figure 4B. 
This suggests a tradeoff between using better rules to build the models (those in which 
clinician agree with the empirical risk) and oversimplifying the model (if only rules with ΔR = 0 
are used). Therefore, better results might be obtained if we had acquired clinicians’ answers for 
all 2000 rules and not just the 126 selected by Lasso. The tradeoff in this case is time to 
acquire the answers. 

Additionally, in Figure 4C we note that models with the highest accuracy can be obtained with 
half the data if clinicians’ answers are used to limit rules used for training: models built with 
rules from groups 1 and 2, i.e. ΔR ≤ 2, saturate around 400 patients while those built with all 
the rules need around 800 patients. T-tests comparing performance of models trained on 6400 
cases (saturation) using only rules with ranking difference ≤ 2 versus all rules show the reduced 
rule set results in significantly better AUC (t = 4.14; p = 7.36e-04) and balanced accuracy (t = 
5.45; p = 3.56e-05). This effect is not present if the model is trained and tested on MIMIC-III 
data (Figure 4D). Figures 4 B-D exemplify the difficulties and limitations of selecting the best 
models using cross-validated errors estimated from the empirical distribution.  Upon covariate 
shifts and data acquired at a different time (possibly reflecting new interventions, new drugs, 
etc), model selection using cross-validation from the empirical distribution is no longer optimal 
because spurious correlations found in the empirical distribution are likely to change. Since 
true causal knowledge will not change, our results suggest that, this knowledge is being 
extracted from clinicians (e.g. evaluation of PaO2/FiO2 by clinicians). Finally, similar results can 
be obtained if instead of using the hard version of EAML, we use a soft version (Supplementary 
material). 

Discussion 
Despite recent success and wide popularity, ML algorithms today are data inefficient and 
generalize poorly to unseen cases. We have introduced MediForests, the first tool to 
automatically extract prior clinical knowledge from clinicians, and EAML, an algorithm that 
incorporates this knowledge into ML models. Related work in the past had attempted to 
predict risk based on clinicians’ assessment of individual cases using all available patient 
characteristics19. Here, in contrast, we transformed the raw physiologic data into a set of 
simple rules and ask clinicians to assess subpopulations. We show how this extracted prior 
knowledge allows: 1) discovery of hidden confounders and limitations on clinicians’ knowledge 
2) better generalization to changes in the underlying feature distribution 3) improved accuracy 
time decay, 4) training with less data and 5) illustrate the limitations of models chosen using 
crossvalidation estimated from the empirical distribution. Specifically, analyzing the MIMIC 
dataset from the PhysioNet project7,8 we showed how MediForests allowed the discovery of a 
hidden confounder (intubation) that can change the interpretation of common variables used to 
model mortality of patients in the Intensive Care Unit in many clinically available scores 
(APACHE,9 SAPS II20 or SOFA11). Google Scholar lists over ten thousand citations of the 
PhysioNet project as of December 2018, with approximately 1600 new papers published every 
year. Conclusions about treatment effect or variable importance using this dataset should be 
taken with caution, especially since the concept of intubation can be implicitly learned from the 
data, as shown here, even when the variable is not recorded. Moreover, we have also identified 
areas where clinicians’ knowledge may need re-evaluation, such as the case of older patients 
that have otherwise favorable physiologic profiles. Further investigation is warranted to 
establish whether the perceived risk is driving treatment decisions. The ranking difference of all 
the rules analyzed have been included in the supplemental material for others to analyze.

We have built EAML to incorporate clinicians’ knowledge along with its uncertainty into the final 
ML model. EAML is not merely a different way of regularizing a machine-learned model but is 
designed to extract domain knowledge not necessarily present in the training data. We have 
shown how incorporating this prior knowledge helps the algorithm generalize better to changes 
in the underlying variable distributions which happened after a reacquisition of the database by 
the PhysioNet Project and a reconstruction of the data for this study. We have also 
demonstrated that the models can be made more robust to accuracy decay with time. 
Moreover, preferentially using those rules where clinicians agree with the empirical data not 
only produces models that generalize better, but it does so with considerably less data (N = 
400 versus N = 800). This result can be of high value for subfields where data is scarce and/or 
expensive to collect. The limitation of selecting models using crossvalidated estimation from 
within the empirical distribution was also demonstrated. We showed that there is no advantage 
in incorporating clinicians’ knowledge if the test set is repeatedly drawn from the same 
distribution as the training. However, when the same model was tested in a distribution whose 
variables have changed or that were acquired at a later time, then including clinicians’ answers 
improved performance and allowed training with less data.  

Finally, this work also has implications on the interpretability of ML algorithms. Up to now, there 
has been a tradeoff between interpretability and accuracy of ML models21,22. However, as 
shown by Friedman et al23, rule ensembles and, as a consequence, EAML, are on average 
more accurate than Random Forest and slightly more accurate than Gradient Boosting in a 
variety of complicated problems. Therefore, EAML also addresses the tradeoff between 
accuracy and interpretability in ML, essential to building trust in predictive models.

Methods 
Dataset 
In this study we have used the publicly available MIMIC dataset from the PhysioNet project. 
This project’s Institutional Review Board (IRB) is approved by the Beth Israel Deaconess 
Medical Center (Boston, MA) and the Massachusetts Institute of Technology (Cambridge, MA). 
Patient consent was not sought because the study did not impact clinical care and protected 
health information was de-identified in compliance with the Health Insurance Portability and 
Accountability Act (HIPAA).  Data Collection and Patients was first performed from 2001-2008 
(MIMIC-II7) while the Beth Israel Deaconess Medical Center used the management software 
CareVue (Philips, Andover, MA). In 2013, the MIMIC-III dataset was acquired8 that included 1) 
the same patients in MIMIC-II but where many data elements were regenerated from the raw 
data in a more robust manner and 2) extra patients treated from 2008-2012. It is important to 
note that in 2008, the Beth Israel Deaconess Medical Center switched from CareVue to 
Metavision (iMDSoft, Wakefield, MA) as their management software. For the sake of this study 
only adult ICU patients (older than 15 years) with a single admission per hospital stay were 
included. The main outcome model was “in hospital morality”. The features used to build our 
prediction algorithms included 13 physiological variables (age, Glasgow coma scale, systolic 
blood pressure, heart rate, body temperature, PaO2/FiO2 ratio, urinary output, serum urea 
nitrogen level, white blood cells count, serum bicarbonate level, sodium level, potassium level 
and bilirubin level), type of admission (scheduled surgical, unscheduled surgical, or medical), 
and three underlying disease variables (acquired immunodeficiency syndrome, metastatic 
cancer, and hematologic malignancy derived from ICD-9 discharge codes). The value of these 
variables were taken as the worse value in the first 24 hours as defined by Le Gall et al20. These 
variables were selected because they are easy to acquire and used in the majority of clinically 
available scores (SOFA11, APACHE9, SAPS10). After collecting clinicians’ answers, besides the 
original features, other features, like intubation, that were hypothesized to explain the 
disagreement between clinicians and empirical data were also collected from MIMIC-III. 

MediForests: Rule Generation Algorithm 
In order to extract information from clinicians, a ML model was constructed by applying the 
RuleFit  algorithm23 to the MIMIC-II dataset. RuleFit first uses Gradient Boosting24 with *
hyperparameters selected to introduce diversity to obtain a large number of decision trees and 
converts them to a set of binary decision rules. For each case, each rule is either 1 or 0, if the 
patient satisfies the criteria. These rules are then used as input features in a LASSO model, 
which performs variable selection, effectively selecting the most important rules. In equation 1, 
we show an example using the quadratic loss function  
                                 (1) 
where     are the coefficients of the rules,   ,  for each observation i that we would 
like to obtain,    is the outcome and     is the lasso shrinkage parameter. The indicator    = 1 if 
observation i belongs to rule k or 0 otherwise. Future observations are predicted using 
equation 2

                                                                                                                   (2)

Note that since equation 1 solves the lasso problem, most coefficients     will be set to 0; 
approximately only 10% of coefficients will be nonzero 23. Friedman et al demonstrated that 
even when modeling complicated functions, approximately 200 rules built from trees of depth 3 
suffice to give models that are competitive in accuracy compared to state-of-the-art algorithms 
like Random Forests25 and Gradient Boosting24. In the present article we applied RuleFit to the 
MIMIC-II database to generate simple rules that were used as building blocks to extract 
knowledge from clinicians. 
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 RuleFit is a trademarked algorithm developed by Drs. Friedman and Popescu.*
Web Application 
A web application was created to collect clinicians’ knowledge. Hospitalists and ICU clinicians 
were contacted by email and compensated $100 USD for participation. 15 clinicians answered 
all questions. Before answering questions, clinicians were asked to watch a video explaining 
the MediForests interface (https://youtu.be/pqDnElOLoxw). In all cases, clinicians were asked 
to evaluate the risk of patients within a given rule relative to the whole population and select 
from 5 different categories (highly decrease (1), moderately decrease (2), no effect (3), 
moderately increase (4) and highly increase (5)).  The average for each rule over the committee 
of clinician was taken as the clinicians’ perceived risk, Rk. The standard deviation over 
clinicians’ answer for each rule k, STDVk, was taken as a measurement of clinicians’ 
agreement. Additionally, rules were ranked according to the perceived risk from lowest to 
highest, Rankp. This ranking represents the acquired clinicians’ knowledge.  Rules were also 
ranked according to the mortality ratio of patients within the rule, Ranke. The difference 
between Rankp and Ranke, ΔR = Rankp - Ranke, was taken as a direct measurement of the 
disagreement between the clinicians’ perceived risk and the empirical risk. Rules with ΔR 
outside the 90% confidence interval were investigated. 

Expert-Augmented Machine Learning 
In order to incorporate clinicians’ knowledge (represented by ΔR and STDV) into the ML model, 
we designed the Expert Augmented Machine Learning algorithm (EAML). In its most general 
form, EAML is a group-penalized regression26 where each rule is penalized as a function of the 
clinician’s disagreement with the data, ΔRk, and a measurement of trust in this disagreement, 
STDVk, such that:

  
    (3) 
where L is a general loss function and    is the norm m of the vector c.  
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For instance if we take     and m =1, we have that those rules 
where clinicians disagree with the data, (higher   ),  get penalized more for bigger   . 
Additionally, those rules where clinicians do not agree, characterized by a higher STDVk, will 
get penalized less for the same   . Finally, the parameters    controls the level of trust we 
put on clinicians’ knowledge vs the data. For   , only rules with    will be 
included in the model (complete trust on the clinicians’ answer). For   , the clinicians’ 
knowledge is discarded.  In general, lambda is a hyperparamter and should be a selected as a 
function of the quality of the data and the clinicians’ knowledge about a certain problem,  

   
All analysis and visualization were performed using the rtemis machine learning library27.
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Supplementary Information 
1. Video:  This link https://youtu.be/pqDnElOLoxw

includes the video watched by physicians’ before answering questions. 

2. Supplementary Table(s) and Figures (S)

Below we have included an excel file with the average empirical ranking, standard 
deviation, Rankp and Ranke for each rule.  Although grouped penalized 
regularization has been used in our case to develop EAML, other algorithms that use 
the ranking difference can be envisioned as well.  The following scale have been 
used for the variables specified below:

Glasgow Coma Scale (GCS):  1:< 6; 2:6-8; 3: 9-1; 4:11-13; 5:14-15

Renal Function:  0: Serum creatinine <110 micromol/l (<12 mg/l); 1: Serum creatinine 
110-170 micromol/l (12-19 mg/l); 2: Serum creatinine 171-299 micromol/l (20-34 mg/l); 
3: Serum creatinine 300-440 micromol/l (35-49 mg/l) or Urine output <500ml/day; 
4: Serum creatinine >440 micromol/l (>50 mg/l) or Urine output <200ml/day

3. Supplementary Equation(s) and Figures(s)

Besides, showing the value of physicians’ answers with a hard version of EAML and 
the limitations of cross-validation to select robust models, we have also shown it 
with a soft EAML. Please find below the optimization problem solved on soft EAML: 

  (S.1)

On equation S1 we have introduced the parameter     to control the relative extra 
penalization compared to ridge penalization that rules that disagree more with physicians 
will have. If    then Ridge regression is recovered. If   , then regular linear 
regression is recovered regardless of     . Additionally, the term     , 
which indicates the maximum value of the standard deviation among all the rules, has 
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been added to the denominator so that the maximum variation that the standard deviation 
can introduced is 20% of the original      . Figure S1 shows the effect of different   
  on the training and validation set on MIMIC-II and on MIMIC-III1 and MIMIC-III2. As it 
can be seen on Figure S1 a) and b), if the algorithm is allowed to see the training data then 
both in training and testing it prefers no regularization (    gives the best results but as 
soon we test on MIMIC-III1 and MIMIC-III2 then    indicating the value on physicians’ 
answers. 

  

Figure S1. Effect of building models on 70% of MIMIC-II with soft EAML and evaluating 
on A) training data B) 30% test data C) MIMIC-III1 and D) MIMIC-III2. 
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